Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ)
CNY 4.11
(2.49%)
CNY 4.11
(2.49%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.11 Billion CNY | -6.3% |
| 2022 | 1.24 Billion CNY | -7.38% |
| 2021 | 1.34 Billion CNY | -0.05% |
| 2020 | 1.34 Billion CNY | -9.83% |
| 2019 | 1.49 Billion CNY | 8.67% |
| 2018 | 1.37 Billion CNY | 59.91% |
| 2017 | 859.18 Million CNY | 149.91% |
| 2016 | 343.79 Million CNY | 41.88% |
| 2015 | 242.32 Million CNY | 124.51% |
| 2014 | 107.93 Million CNY | 11.34% |
| 2013 | 96.93 Million CNY | 11.66% |
| 2012 | 86.81 Million CNY | 43.12% |
| 2011 | 60.66 Million CNY | -10.62% |
| 2010 | 67.86 Million CNY | 31.83% |
| 2009 | 51.48 Million CNY | 94.68% |
| 2008 | 26.44 Million CNY | 143.12% |
| 2007 | 10.87 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 262.67 Million CNY | -9.63% |
| 2024 Q3 | 208.77 Million CNY | -25.86% |
| 2024 Q1 | 290.67 Million CNY | -0.51% |
| 2023 Q3 | 275.18 Million CNY | -5.2% |
| 2023 Q1 | 310.34 Million CNY | 1.11% |
| 2023 FY | 1.16 Billion CNY | -6.3% |
| 2023 Q4 | 292.17 Million CNY | 6.18% |
| 2023 Q2 | 290.26 Million CNY | -6.47% |
| 2022 Q1 | 306.57 Million CNY | -5.33% |
| 2022 Q4 | 306.94 Million CNY | -6.34% |
| 2022 Q2 | 305.22 Million CNY | -0.44% |
| 2022 FY | 1.24 Billion CNY | -7.38% |
| 2022 Q3 | 327.72 Million CNY | 7.37% |
| 2021 Q1 | 355.28 Million CNY | 1.76% |
| 2021 Q3 | 335.18 Million CNY | 1.13% |
| 2021 Q4 | 323.84 Million CNY | -3.38% |
| 2021 FY | 1.34 Billion CNY | -0.05% |
| 2021 Q2 | 331.43 Million CNY | -6.71% |
| 2020 Q4 | 349.14 Million CNY | -7.98% |
| 2020 Q3 | 379.43 Million CNY | 23.88% |
| 2020 Q2 | 306.3 Million CNY | -1.27% |
| 2020 Q1 | 310.23 Million CNY | -14.18% |
| 2020 FY | 1.34 Billion CNY | -9.83% |
| 2019 FY | 1.49 Billion CNY | 8.67% |
| 2019 Q4 | 361.49 Million CNY | -3.52% |
| 2019 Q3 | 374.69 Million CNY | 0.91% |
| 2019 Q2 | 371.31 Million CNY | -3.23% |
| 2019 Q1 | 383.7 Million CNY | 12.83% |
| 2018 Q3 | 314.4 Million CNY | -4.74% |
| 2018 FY | 1.37 Billion CNY | 59.91% |
| 2018 Q1 | 388.53 Million CNY | 15.66% |
| 2018 Q2 | 330.04 Million CNY | -15.05% |
| 2018 Q4 | 340.07 Million CNY | 8.17% |
| 2017 FY | 859.18 Million CNY | 149.91% |
| 2017 Q2 | 143.59 Million CNY | 27.99% |
| 2017 Q4 | 335.91 Million CNY | 25.92% |
| 2017 Q1 | 112.19 Million CNY | -7.14% |
| 2017 Q3 | 266.77 Million CNY | 85.79% |
| 2016 Q3 | 85.53 Million CNY | 12.21% |
| 2016 FY | 343.79 Million CNY | 41.88% |
| 2016 Q4 | 120.81 Million CNY | 41.25% |
| 2016 Q2 | 76.22 Million CNY | 24.48% |
| 2016 Q1 | 61.23 Million CNY | -24.72% |
| 2015 Q1 | 26.95 Million CNY | -18.65% |
| 2015 Q3 | 74.12 Million CNY | 23.72% |
| 2015 FY | 242.32 Million CNY | 124.51% |
| 2015 Q4 | 81.33 Million CNY | 9.73% |
| 2015 Q2 | 59.91 Million CNY | 122.3% |
| 2014 Q4 | 33.12 Million CNY | 24.32% |
| 2014 FY | 107.93 Million CNY | 11.34% |
| 2014 Q1 | 22.79 Million CNY | -18.15% |
| 2014 Q2 | 25.36 Million CNY | 11.25% |
| 2014 Q3 | 26.64 Million CNY | 5.07% |
| 2013 Q4 | 27.85 Million CNY | 25.54% |
| 2013 FY | 96.93 Million CNY | 11.66% |
| 2013 Q1 | 22.39 Million CNY | -7.19% |
| 2013 Q2 | 24.51 Million CNY | 9.45% |
| 2013 Q3 | 22.18 Million CNY | -9.49% |
| 2012 FY | 86.81 Million CNY | 43.12% |
| 2012 Q3 | 21.3 Million CNY | -4.31% |
| 2012 Q1 | 19.11 Million CNY | -4.98% |
| 2012 Q4 | 24.12 Million CNY | 13.25% |
| 2012 Q2 | 22.26 Million CNY | 16.5% |
| 2011 Q3 | 14.71 Million CNY | 1.41% |
| 2011 Q4 | 20.11 Million CNY | 36.72% |
| 2011 Q2 | 14.5 Million CNY | 28.12% |
| 2011 FY | 60.66 Million CNY | -10.62% |
| 2011 Q1 | 11.32 Million CNY | -40.98% |
| 2010 Q2 | 20.42 Million CNY | 59.76% |
| 2010 Q1 | 12.78 Million CNY | 0.0% |
| 2010 Q4 | 19.18 Million CNY | 23.93% |
| 2010 Q3 | 15.48 Million CNY | -24.19% |
| 2010 FY | 67.86 Million CNY | 31.83% |
| 2009 FY | 51.48 Million CNY | 94.68% |
| 2008 FY | 26.44 Million CNY | 143.12% |
| 2007 FY | 10.87 Million CNY | 0.0% |